A Clinical Trial on the Effect of Guduci (Tinospora Cordifolia (Willd) Miers) Satva along with Ksheera in Perimenopausal Symptoms

Thulasi V S; Giby Thomas; Shahina Mole S

doi:10.47070/ijapr.v10i3.1749

Thulasi V S Assistant Professor, Department of Prasutitantra and Striroga, Parul Institute of Ayurved, Parul University, Vadodara, Gujarat, India
Giby Thomas Associate Professor, Department of Prasutitantra - Streeroga, Government Ayurveda College, Thiruvananthapuram.
Shahina Mole S Professor, Department of Prasutitantra - Streeroga, Government Ayurveda College, Thiruvananthapuram.

DOI: https://doi.org/10.47070/ijapr.v10i3.1749

Keywords: Rajakshaya, Guducisatva, Medhyarasayanam, vayastapana, Greene Climacteric scale

Abstract

Perimenopause refers to the period around menopause. In Ayurveda it is considered as Rajakshaya, the transition period of body from predominance of Pitta dosha to Vatadosha which is characterized by aggravation of Vata, alteration of Pitta and Kaphadosha. It is included as a Swabhavikavyadhi in Ayurveda. Management of Dhatukshaya, Rasayana, Balya and Rasa- Raktha Prasadana treatments are seen beneficial in this condition. Guduci is one among Rasayana drugs mentioned in Ayurveda. The drug Guducisatva taken for the study is from the classic Yogaratnakara and has Dhatukrith and Vayastapana property. The objective of the study was to evaluate the effect of 1g Guduci Satva along with Ksheera (25ml boiled and lukewarm) in perimenopausal symptoms. Females in the age group 40-50 years with perimenopausal symptoms were selected for the study from the OPD of Prasutitantra-striroga, GAVC Hospital, Tripunithura as per the inclusion criteria. Study tools are clinical case proforma and Greene Climacteric scale score above 30. Drug was given orally in the dose of 1g twice along with 25ml Ksheera one hour before food. Duration of administration was 30 days and assessment was taken on 0^thday, 31^stday and 60^thday. Results were analysed statistically by Wilcoxon's signed rank test and Friedman’s test. The study result is highly significant after treatment with P value <0.001 during treatment and during follow up and is found effective in reducing the symptoms in perimenopause.